Agreement relates to vaccine candidate using Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant system Both companies are committed to making …
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept